Listen to this article2023-01-06T17:11:51Z Pfizer logo is seen in this illustration taken, May 1, 2022. REUTERS/Dado Ruvic/Illustration China is in talks with Pfizer Inc (PFE.N) to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firm’s COVID-19 antiviral drug Paxlovid in China, three sources told Reuters. China’s medical products […]
The post Exclusive: China in talks with Pfizer for generic COVID drug first appeared on The Brooklyn News.
Brooklyn News – bklynnews.com
